'Chameleon compounds' offer new way to fight brain tumors
Cancer-fighting "chameleon compounds" offer a potentially powerful new approach to treating drug-resistant glioma tumors in the brain and spinal cord.
Stay updated with breaking news from Ranjit Bindra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cancer-fighting "chameleon compounds" offer a potentially powerful new approach to treating drug-resistant glioma tumors in the brain and spinal cord.
A new drug to treat glioblastomas and other similar cancers, prevents the tumor cells from dividing while not harming healthy tissue. Modifi Biosciences, the company spun off from Yale University that will develop the drug, was launched Thursday.
Yale researchers have developed a new class of molecules that target some of the deadliest brain cancers while sparing healthy tissue along the way.
Yale Spinout Modifi Bio announces seed funding...
A medical student who studied by candlelight while living with the violence of civil war in his home country of Syria and a law student who spent her early years living in poverty in El Salvador are among four Yale students who have been selected as